Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9209
    Short Description Mesna injection
    Long Description Injection, mesna, 200 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 2009-01-01
    Date Added 1990-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00143926001 J9209 Mesna injection MESNA HIKMA PHARMACEUTICALS USA INC. 200 MG 10 1 5 5
    00338130501 J9209 Mesna injection Mesnex BAXTER 200 MG 10 1 5 5
    10019095301 J9209 Mesna injection Mesna BAXTER 200 MG 10 1 5 5
    25021020110 J9209 Mesna injection Mesna SAGENT PHARMACEUTICALS INC 200 MG 10 1 5 5
    25021020111 J9209 Mesna injection Mesna SAGENT PHARMACEUTICALS INC 200 MG 10 10 5 50
    63323073310 J9209 Mesna injection Mesna FRESENIUS KABI 200 MG 10 10 5 50
    63323073311 J9209 Mesna injection Mesna FRESENIUS KABI 200 MG 10 1 5 5
    70860020910 J9209 Mesna injection Mesna ATHENEX 200 MG 10 1 5 5
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 200 MG
    HCPCS/CPT Billing Units 0.005
    Total doses ordered
    Billing Units 0.005

    Drug Details

    • Mesna is used to reduce the risk of hemorrhagic cystitis (a condition that causes inflammation of the bladder and can result in serious bleeding) in people who receive ifosfamide (a medication used for the treatment of cancer). Mesna is in a class of medications called cytoprotectants. It works by protecting the bladder against some of the harmful effects of certain chemotherapy medications.